| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.21 | 0.2 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.23 | 0.2 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.23 | 0.1 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.25 | 1e-10 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.28 | 0.1 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.28 | 0.04 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.29 | 0.09 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.31 | 0.04 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.34 | 0.3 |